Literature DB >> 18062925

A case-control study of the HER2 Ile655Val polymorphism and risk of breast cancer in Taiwan.

Su-Chen Lee1, Ming-Feng Hou, Pei-Chen Hsieh, Szu-Hsien Wu, Linda Ann Hou, Hsu Ma, Shin-Meng Tsai, Li-Yu Tsai.   

Abstract

OBJECTIVES: To investigate the HER2 Ile655Val polymorphism in relation to risk of breast cancer in a case-control study in Taiwan. DESIGN AND METHODS: The HER2 polymorphism at codon 655 was analyzed in 424 patients with breast cancer and 318 controls by using the polymerase chain reaction methodology, followed by the restriction fragment-length polymorphism (PCR-RFLP) analysis.
RESULTS: There was a 1.48-fold (95% CI=1.00-2.24) increase in the risk of patients with breast cancer who are Val carrier (Ile/Val and Val/Val genotypes). Furthermore, for the early onset (less than 45 years old) breast cancers with Val carrier, there was a 2.24-fold (95% CI=1.17-4.34) increase in the risk of breast cancer.
CONCLUSIONS: Our results indicate that the Val carrier was associated with increased risks in patients with breast cancer in Taiwan. The association was more apparent in patients who were younger than or equal to 45 years of age.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18062925     DOI: 10.1016/j.clinbiochem.2007.11.005

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  Genetic variability in EGFR, Src and HER2 and risk of colorectal adenoma and cancer.

Authors:  Elizabeth M Poole; Karen Curtin; Li Hsu; Richard J Kulmacz; David J Duggan; Karen W Makar; Liren Xiao; Christopher S Carlson; Martha L Slattery; Bette J Caan; John D Potter; Cornelia M Ulrich
Journal:  Int J Mol Epidemiol Genet       Date:  2011-12-03

2.  HER2 Ile655Val and PTEN IVS4 polymorphisms in patients with breast cancer.

Authors:  Oguz Ozturk; Emel Canbay; Ozlem T Kahraman; M Fatih Seyhan; Fatih Aydogan; Varol Celik; Cihan Uras
Journal:  Mol Biol Rep       Date:  2012-10-21       Impact factor: 2.316

3.  HER2Ile655Val Single Nucleotide Polymorphism Associated with Early-Onset Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis.

Authors:  Tung Nguyen Thanh; Bao Song Nguyen Tran; Ai Phuong Hoang Thi; Thang Tran Binh; Thong Ba Nguyen; Tam Le Minh; Quoc Huy Nguyen Vu; Thuan Dang Cong
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

4.  Human Epidermal Growth Factor Receptor-2 gene polymorphism and breast cancer risk in women from the Northeastern region of Brazil.

Authors:  Carla Solange Escórcio-Dourado; Francisco Adelton Alves-Ribeiro; Jose Charles Lima-Dourado; Alesse Ribeiro Dos Santos; Renato de Oliveira Pereira; Cleciton Braga Tavares; Vladimir Costa Silva; Pedro Vitor Lopes Costa; José Maria Soares-Júnior; Benedito Borges da Silva
Journal:  Clinics (Sao Paulo)       Date:  2020-12-09       Impact factor: 2.365

5.  Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study.

Authors:  Bugi Ratno Budiarto
Journal:  Sci Pharm       Date:  2016-02-14

6.  Her2 Ile655Val polymorphism and its association with breast cancer risk: an updated meta-analysis of case-control studies.

Authors:  B Madhu Krishna; Sanjib Chaudhary; Aditya K Panda; Dipti Ranjan Mishra; Sandip K Mishra
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.